• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,185.56 -430.84
( -0.56%)
Global Indices
Nasdaq
52,524.20 -133.81
(-0.25%)
Dow Jones
7,536.77 -59.62
(-0.78%)
Hang Seng
67,217.35 -1,340.38
(-1.96%)
Nikkei 225
10,494.06 -3.23
(-0.03%)
Forex
USD-INR
95.45 -0.01
(-0.01%)
EUR-INR
109.10 0.17
(0.15%)
GBP-INR
127.94 0.35
(0.28%)
JPY-INR
0.59 0.00
(0.03%)

EQUITY - MARKET SCREENER

Bacil Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524516
INE711D01018
17.5524281
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
34.74
53.85
EPS(TTM)
Face Value()
Div & Yield %
1.08
10
0
 

Mangalam Worldwide consolidated net profit rises 81.25% in the March 2026 quarter
Apr 30,2026
Net profit of Mangalam Worldwide rose 81.25% to Rs 15.37 crore in the quarter ended March 2026 as against Rs 8.48 crore during the previous quarter ended March 2025. Sales declined 18.24% to Rs 264.95 crore in the quarter ended March 2026 as against Rs 324.04 crore during the previous quarter ended March 2025.

For the full year,net profit rose 69.95% to Rs 50.10 crore in the year ended March 2026 as against Rs 29.48 crore during the previous year ended March 2025. Sales rose 13.88% to Rs 1207.98 crore in the year ended March 2026 as against Rs 1060.71 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales264.95324.04 -18 1207.981060.71 14
OPM %10.474.67 -7.525.16 -
PBDT18.978.79 116 61.0236.26 68
PBT16.426.49 153 50.8727.65 84
NP15.378.48 81 50.1029.48 70